{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:40:12Z","timestamp":1792291212746,"version":"4.4.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-03068-x","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:06:28Z","timestamp":1768896388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Insulin resistance and coronary microvascular dysfunction: a complex interplay"],"prefix":"10.1186","volume":"25","author":[{"given":"Martina","family":"Magistri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Portolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Trevisanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Piana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rubinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Molinaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kunadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Scarsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"13","key":"3068_CR1","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246\u201358.","journal-title":"World J Diabetes"},{"issue":"37","key":"3068_CR2","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"V Kunadian","year":"2020","unstructured":"Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas A, et al. An EAPCI expert consensus document on ischaemia with Non-Obstructive coronary arteries in collaboration with European society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group. Eur Heart J. 2020;41(37):3504\u201320.","journal-title":"Eur Heart J"},{"issue":"23 Pt A","key":"3068_CR3","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","volume":"72","author":"TJ Ford","year":"2018","unstructured":"Ford TJ, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, et al. Stratified medical therapy using invasive coronary function testing in angina: the cormica trial. J Am Coll Cardiol. 2018;72(23 Pt A):2841\u201355.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"3068_CR4","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.jcin.2020.05.052","volume":"13","author":"TJ Ford","year":"2020","unstructured":"Ford TJ, Ong P, Sechtem U, Beltrame J, Camici PG, Crea F, et al. Assessment of vascular dysfunction in patients without obstructive coronary artery disease: Why, How, and when. JACC Cardiovasc Interv. 2020;13(16):1847\u201364.","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"3068_CR5","doi-asserted-by":"publisher","first-page":"e003995","DOI":"10.1161\/JAHA.116.003995","volume":"5","author":"M Sezer","year":"2016","unstructured":"Sezer M, Kocaaga M, Aslanger E, Atici A, Demirkiran A, Bugra Z, et al. Bimodal pattern of coronary microvascular involvement in diabetes mellitus. J Am Heart Assoc. 2016;5(11):e003995.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"3068_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685\u201395.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"3068_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981\u20131030.","journal-title":"Endocr Rev"},{"issue":"5","key":"3068_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","volume":"10","author":"M Laakso","year":"2014","unstructured":"Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293\u2013302.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"3068_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2337\/dc06-0919","volume":"30","author":"E Bonora","year":"2007","unstructured":"Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care. 2007;30(2):318\u201324.","journal-title":"Diabetes Care"},{"issue":"3","key":"3068_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013;28(3):777\u201384.","journal-title":"Hum Reprod"},{"issue":"9468","key":"3068_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415\u201328.","journal-title":"Lancet"},{"issue":"1","key":"3068_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3068_CR13","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2265.2004.02156.x","volume":"61","author":"N Dagres","year":"2004","unstructured":"Dagres N, Saller B, Haude M, Husing J, von Birgelen C, Schmermund A, et al. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol (Oxf). 2004;61(6):724\u201331.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"3068_CR14","doi-asserted-by":"publisher","first-page":"E1250","DOI":"10.1152\/ajpendo.00451.2007","volume":"293","author":"Z Liu","year":"2007","unstructured":"Liu Z. Insulin at physiological concentrations increases microvascular perfusion in human myocardium. Am J Physiol Endocrinol Metab. 2007;293(5):E1250\u20135.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"3068_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ecl.2008.06.001","volume":"37","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa R, Iantorno M, Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am. 2008;37(3):685\u2013711. ix-x.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"3068_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/HJH.0b013e3283340da8","volume":"28","author":"MS Zhou","year":"2010","unstructured":"Zhou MS, Schulman IH, Raij L. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. J Hypertens. 2010;28(3):527\u201335.","journal-title":"J Hypertens"},{"issue":"3","key":"3068_CR17","doi-asserted-by":"publisher","first-page":"300060523116454","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51(3):3000605231164548.","journal-title":"J Int Med Res"},{"issue":"1","key":"3068_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1096\/fj.05-4197fje","volume":"20","author":"T Kanda","year":"2006","unstructured":"Kanda T, Wakino S, Homma K, Yoshioka K, Tatematsu S, Hasegawa K, et al. Rho-kinase as a molecular target for insulin resistance and hypertension. FASEB J. 2006;20(1):169\u201371.","journal-title":"FASEB J"},{"issue":"157","key":"3068_CR19","doi-asserted-by":"publisher","first-page":"ra3","DOI":"10.1126\/scisignal.2001227","volume":"4","author":"Y Hara","year":"2011","unstructured":"Hara Y, Wakino S, Tanabe Y, Saito M, Tokuyama H, Washida N, et al. Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that May involve mechanical stretch. Sci Signal. 2011;4(157):ra3.","journal-title":"Sci Signal"},{"issue":"1","key":"3068_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/biof.3","volume":"35","author":"G Wu","year":"2009","unstructured":"Wu G, Meininger CJ. Nitric oxide and vascular insulin resistance. BioFactors. 2009;35(1):21\u20137.","journal-title":"BioFactors"},{"issue":"10","key":"3068_CR21","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.2337\/diabetes.52.10.2562","volume":"52","author":"CC Wang","year":"2003","unstructured":"Wang CC, Gurevich I, Draznin B. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes. 2003;52(10):2562\u20139.","journal-title":"Diabetes"},{"issue":"6","key":"3068_CR22","first-page":"585","volume":"21","author":"S Matthaei","year":"2000","unstructured":"Matthaei S, Stumvoll M, Kellerer M, Haring HU. Pathophysiology and Pharmacological treatment of insulin resistance. Endocr Rev. 2000;21(6):585\u2013618.","journal-title":"Endocr Rev"},{"issue":"8","key":"3068_CR23","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.2337\/dbi16-0026","volume":"65","author":"G Jia","year":"2016","unstructured":"Jia G, Durante W, Sowers JR. Endothelium-Derived hyperpolarizing factors: A potential therapeutic target for vascular dysfunction in obesity and insulin resistance. Diabetes. 2016;65(8):2118\u201320.","journal-title":"Diabetes"},{"issue":"15","key":"3068_CR24","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.3390\/ijms20153737","volume":"20","author":"K Goto","year":"2019","unstructured":"Goto K, Kitazono T. Endothelium-Dependent hyperpolarization (EDH) in diabetes: mechanistic insights and therapeutic implications. Int J Mol Sci. 2019;20(15):3737.","journal-title":"Int J Mol Sci"},{"issue":"9833","key":"3068_CR25","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tabak","year":"2012","unstructured":"Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279\u201390.","journal-title":"Lancet"},{"issue":"3","key":"3068_CR26","first-page":"644","volume":"13","author":"S Lamprou","year":"2023","unstructured":"Lamprou S, Koletsos N, Mintziori G, Anyfanti P, Trakatelli C, Kotsis V, et al. Microvascular and endothelial dysfunction in prediabetes. Life (Basel). 2023;13(3):644.","journal-title":"Life (Basel)"},{"issue":"1","key":"3068_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/BST20200611","volume":"49","author":"AM Clyne","year":"2021","unstructured":"Clyne AM. Endothelial response to glucose: dysfunction, metabolism, and transport. Biochem Soc Trans. 2021;49(1):313\u201325.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"3068_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10456-022-09835-8","volume":"25","author":"D Sun","year":"2022","unstructured":"Sun D, Wang J, Toan S, Muid D, Li R, Chang X, et al. Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance. Angiogenesis. 2022;25(3):307\u201329.","journal-title":"Angiogenesis"},{"issue":"1","key":"3068_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-019-0833-1","volume":"18","author":"JD Sara","year":"2019","unstructured":"Sara JD, Taher R, Kolluri N, Vella A, Lerman LO, Lerman A. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease. Cardiovasc Diabetol. 2019;18(1):22.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3068_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2337\/dc22-0783","volume":"46","author":"P Mone","year":"2023","unstructured":"Mone P, Lombardi A, Salemme L, Cioppa A, Popusoi G, Varzideh F, et al. Stress hyperglycemia drives the risk of hospitalization for chest pain in patients with ischemia and nonobstructive coronary arteries (INOCA). Diabetes Care. 2023;46(2):450\u20134.","journal-title":"Diabetes Care"},{"issue":"7","key":"3068_CR31","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/00004872-199816070-00001","volume":"16","author":"E Ferrannini","year":"1998","unstructured":"Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens. 1998;16(7):895\u2013906.","journal-title":"J Hypertens"},{"issue":"3","key":"3068_CR32","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214\u201323.","journal-title":"Am J Physiol"},{"issue":"11","key":"3068_CR33","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1210\/jc.2010-2167","volume":"95","author":"TA Buchanan","year":"2010","unstructured":"Buchanan TA, Watanabe RM, Xiang AH. Limitations in surrogate measures of insulin resistance. J Clin Endocrinol Metab. 2010;95(11):4874\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"3068_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"7","key":"3068_CR35","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3068_CR36","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462\u201370.","journal-title":"Diabetes Care"},{"issue":"1","key":"3068_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12933-024-02241-y","volume":"23","author":"JL Yin","year":"2024","unstructured":"Yin JL, Yang J, Song XJ, Qin X, Chang YJ, Chen X, et al. Triglyceride-glucose index and health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies. Cardiovasc Diabetol. 2024;23(1):177.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"3068_CR38","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1056\/NEJMoa0907272","volume":"362","author":"MR Patel","year":"2010","unstructured":"Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886\u201395.","journal-title":"N Engl J Med"},{"issue":"3","key":"3068_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407\u201377.","journal-title":"Eur Heart J"},{"key":"3068_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf839","author":"S Miner","year":"2025","unstructured":"Miner S, Mejia-Renteria H, Leone AM, Velollari O, Sykes R, Biscaglia S et al. Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study. Eur Heart J. 2025. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf839","journal-title":"Eur Heart J"},{"issue":"36","key":"3068_CR41","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"7","key":"3068_CR42","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10554-017-1136-9","volume":"33","author":"H Mejia-Renteria","year":"2017","unstructured":"Mejia-Renteria H, van der Hoeven N, van de Hoef TP, Heemelaar J, Ryan N, Lerman A, et al. Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests. Int J Cardiovasc Imaging. 2017;33(7):1041\u201359.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"3068_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00395-020-0778-2","volume":"115","author":"J van de Wouw","year":"2020","unstructured":"van de Wouw J, Sorop O, van Drie RWA, van Duin RWB, Nguyen ITN, Joles JA, et al. Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease. Basic Res Cardiol. 2020;115(2):21.","journal-title":"Basic Res Cardiol"},{"issue":"21","key":"3068_CR44","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","volume":"72","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC State-of-the-Art review. J Am Coll Cardiol. 2018;72(21):2625\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"3068_CR45","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","volume":"78","author":"MG Del Buono","year":"2021","unstructured":"Del Buono MG, Montone RA, Camilli M, Carbone S, Narula J, Lavie CJ, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC State-of-the-Art review. J Am Coll Cardiol. 2021;78(13):1352\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"3068_CR46","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.109.900191","volume":"121","author":"GA Lanza","year":"2010","unstructured":"Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121(21):2317\u201325.","journal-title":"Circulation"},{"issue":"22","key":"3068_CR47","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.3390\/ijms20225563","volume":"20","author":"E Zanatta","year":"2019","unstructured":"Zanatta E, Colombo C, D\u2019Amico G, d\u2019Humieres T, Dal Lin C, Tona F. Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases. Int J Mol Sci. 2019;20(22):5563.","journal-title":"Int J Mol Sci"},{"issue":"45","key":"3068_CR48","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1093\/eurheartj\/ehv100","volume":"36","author":"AR Pries","year":"2015","unstructured":"Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ, et al. Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J. 2015;36(45):3134\u201346.","journal-title":"Eur Heart J"},{"issue":"5","key":"3068_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41569-023-00953-4","volume":"21","author":"M Galli","year":"2024","unstructured":"Galli M, Niccoli G, De Maria G, Brugaletta S, Montone RA, Vergallo R, et al. Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction. Nat Rev Cardiol. 2024;21(5):283\u201398.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"3068_CR50","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","volume":"59","author":"P Ong","year":"2012","unstructured":"Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA study (Abnormal coronary vasomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59(7):655\u201362.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3068_CR51","doi-asserted-by":"publisher","first-page":"504","DOI":"10.23736\/S2724-5683.23.06414-1","volume":"71","author":"R Scarsini","year":"2023","unstructured":"Scarsini R, Campo G, L DIS, Zanon S, Rubino F, Monizzi G, et al. #FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice. Minerva Cardiol Angiol. 2023;71(5):504\u201314.","journal-title":"Minerva Cardiol Angiol"},{"issue":"8 Pt 2","key":"3068_CR52","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jcmg.2018.10.032","volume":"12","author":"A Gulati","year":"2019","unstructured":"Gulati A, Ismail TF, Ali A, Hsu LY, Goncalves C, Ismail NA, et al. Microvascular dysfunction in dilated cardiomyopathy: A quantitative stress perfusion cardiovascular magnetic resonance study. JACC Cardiovasc Imaging. 2019;12(8 Pt 2):1699\u2013708.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"3068_CR53","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jcmg.2023.01.017","volume":"16","author":"R Scarsini","year":"2023","unstructured":"Scarsini R, Portolan L, Della Mora F, Marin F, Mainardi A, Ruzzarin A, et al. Angiography-Derived and Sensor-Wire methods to assess coronary microvascular dysfunction in patients with acute myocardial infarction. JACC Cardiovasc Imaging. 2023;16(7):965\u201381.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"3068_CR54","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jcmg.2010.04.007","volume":"3","author":"TH Schindler","year":"2010","unstructured":"Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging. 2010;3(6):623\u201340.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"3068_CR55","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.jcmg.2021.02.023","volume":"14","author":"R Scarsini","year":"2021","unstructured":"Scarsini R, Shanmuganathan M, De Maria GL, Borlotti A, Kotronias RA, Burrage MK, et al. Coronary microvascular dysfunction assessed by pressure wire and CMR after STEMI predicts Long-Term outcomes. JACC Cardiovasc Imaging. 2021;14(10):1948\u201359.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"14","key":"3068_CR56","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jacc.2007.06.027","volume":"50","author":"L Cortigiani","year":"2007","unstructured":"Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol. 2007;50(14):1354\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"3068_CR57","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s10554-023-02948-1","volume":"39","author":"SM Jensen","year":"2023","unstructured":"Jensen SM, Prescott EIB, Abdulla J. The prognostic value of coronary flow reserve in patients with non-obstructive coronary artery disease and microvascular dysfunction: a systematic review and meta-analysis with focus on imaging modality and sex difference. Int J Cardiovasc Imaging. 2023;39(12):2545\u201356.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"3068_CR58","first-page":"192","volume":"76","author":"M Petretta","year":"2011","unstructured":"Petretta M, Acampa W, Zampella E, Assante R, Petretta MP, Cuocolo R, et al. Imaging techniques for assessment of coronary flow reserve. Monaldi Arch Chest Dis. 2011;76(4):192\u20137.","journal-title":"Monaldi Arch Chest Dis"},{"issue":"22","key":"3068_CR59","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1016\/j.jcin.2023.09.027","volume":"16","author":"E Gallinoro","year":"2023","unstructured":"Gallinoro E, Bertolone DT, Mizukami T, Paolisso P, Bermpeis K, Munhoz D, et al. Continuous vs bolus thermodilution to assess microvascular resistance reserve. JACC Cardiovasc Interv. 2023;16(22):2767\u201377.","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"3068_CR60","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3390\/biomedicines10092274","volume":"10","author":"T Salvatore","year":"2022","unstructured":"Salvatore T, Galiero R, Caturano A, Vetrano E, Loffredo G, Rinaldi L, et al. Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options. Biomedicines. 2022;10(9):2274.","journal-title":"Biomedicines"},{"issue":"1","key":"3068_CR61","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2337\/diacare.27.1.208","volume":"27","author":"A Nitenberg","year":"2004","unstructured":"Nitenberg A, Valensi P, Sachs R, Cosson E, Attali JR, Antony I. Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors. Diabetes Care. 2004;27(1):208\u201315.","journal-title":"Diabetes Care"},{"key":"3068_CR62","doi-asserted-by":"publisher","first-page":"ehad655","DOI":"10.1093\/eurheartj\/ehad655.1192","volume":"44","author":"E Gallinoro","year":"2023","unstructured":"Gallinoro E, Paolisso P, Bertolone DT, Belmonte M, Esposito G, Munhoz D, et al. Endotypes of coronary microvascular dysfunction in patients with and without diabetes mellitus. Eur Heart J. 2023;44:ehad655.","journal-title":"Eur Heart J"},{"issue":"6","key":"3068_CR63","doi-asserted-by":"publisher","first-page":"H2279","DOI":"10.1152\/ajpheart.00615.2011","volume":"301","author":"A Picchi","year":"2011","unstructured":"Picchi A, Limbruno U, Focardi M, Cortese B, Micheli A, Boschi L, et al. Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients. Am J Physiol Heart Circ Physiol. 2011;301(6):H2279\u201384.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"3068_CR64","first-page":"48","volume":"13","author":"M Caliskan","year":"2013","unstructured":"Caliskan M, Pamuk BO, Gullu H, Ciftci O, Caliskan Z, Erdogan D, et al. Effect of family history of type-2 diabetes on coronary flow reserve and it\u2019s relationship with insulin resistance: an observational study. Anadolu Kardiyol Derg. 2013;13(1):48\u201356.","journal-title":"Anadolu Kardiyol Derg"},{"issue":"5","key":"3068_CR65","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1253\/circj.CJ-21-0549","volume":"86","author":"Y Takei","year":"2022","unstructured":"Takei Y, Tomiyama H, Tanaka N, Yamashina A, Chikamori T. Association between insulin Resistance, oxidative Stress, sympathetic activity and coronary microvascular function in patients with early stage impaired glucose metabolism. Circ J. 2022;86(5):866\u201373.","journal-title":"Circ J"},{"key":"3068_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1475-2840-13-73","volume":"13","author":"D Trifunovic","year":"2014","unstructured":"Trifunovic D, Stankovic S, Sobic-Saranovic D, Marinkovic J, Petrovic M, Orlic D, et al. Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function. Cardiovasc Diabetol. 2014;13:73.","journal-title":"Cardiovasc Diabetol"},{"issue":"4\u20135","key":"3068_CR67","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/10739680701282887","volume":"14","author":"JD Knudson","year":"2007","unstructured":"Knudson JD, Dincer UD, Bratz IN, Sturek M, Dick GM, Tune JD. Mechanisms of coronary dysfunction in obesity and insulin resistance. Microcirculation. 2007;14(4\u20135):317\u201338.","journal-title":"Microcirculation"},{"issue":"16","key":"3068_CR68","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1161\/CIRCULATIONAHA.111.037283","volume":"124","author":"GA Lanza","year":"2011","unstructured":"Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation. 2011;124(16):1774\u201382.","journal-title":"Circulation"},{"issue":"23","key":"3068_CR69","doi-asserted-by":"publisher","first-page":"14214","DOI":"10.1074\/jbc.270.23.14214","volume":"270","author":"HB Peng","year":"1995","unstructured":"Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates Inhibition of NF-kappa B. J Biol Chem. 1995;270(23):14214\u20139.","journal-title":"J Biol Chem"},{"issue":"15","key":"3068_CR70","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","volume":"113","author":"JA Kim","year":"2006","unstructured":"Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888\u2013904.","journal-title":"Circulation"},{"issue":"6865","key":"3068_CR71","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799\u2013806.","journal-title":"Nature"},{"issue":"3","key":"3068_CR72","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s00125-024-06292-4","volume":"68","author":"CA Shibao","year":"2025","unstructured":"Shibao CA, Peche VS, Pietka TA, Samovski D, Williams IM, Abumrad NN, et al. Microvascular insulin resistance with enhanced muscle glucose disposal in CD36 deficiency. Diabetologia. 2025;68(3):662\u201375.","journal-title":"Diabetologia"},{"issue":"1","key":"3068_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5603\/EP.a2021.0002","volume":"72","author":"P Estrella Ibarra","year":"2021","unstructured":"Estrella Ibarra P, Garcia-Solis P, Solis-Sainz JC, Cruz-Hernandez A. Expression of MiRNA in obesity and insulin resistance: a review. Endokrynol Pol. 2021;72(1):73\u201380.","journal-title":"Endokrynol Pol"},{"issue":"1","key":"3068_CR74","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12933-024-02331-x","volume":"23","author":"M Ferrone","year":"2024","unstructured":"Ferrone M, Ciccarelli M, Varzideh F, Kansakar U, Guerra G, Cerasuolo FA, et al. Endothelial MicroRNAs in INOCA patients with diabetes mellitus. Cardiovasc Diabetol. 2024;23(1):268.","journal-title":"Cardiovasc Diabetol"},{"key":"3068_CR75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2015.03.118","volume":"185","author":"RH Olsen","year":"2015","unstructured":"Olsen RH, Pedersen LR, Jurs A, Snoer M, Haugaard SB, Prescott E. A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease. Int J Cardiol. 2015;185:229\u201335.","journal-title":"Int J Cardiol"},{"key":"3068_CR76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mvr.2014.07.015","volume":"95","author":"M Klonizakis","year":"2014","unstructured":"Klonizakis M, Alkhatib A, Middleton G. Long-term effects of an exercise and mediterranean diet intervention in the vascular function of an older, healthy population. Microvasc Res. 2014;95:103\u20137.","journal-title":"Microvasc Res"},{"issue":"4","key":"3068_CR77","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/cvr\/cvae269","volume":"121","author":"P Mone","year":"2025","unstructured":"Mone P, Varzideh F, Rainone A, Kansakar U, Jankauskas SS, Salemme L, et al. Beneficial effects of Metformin treatment in hyperglycaemic patients affected by ischaemia with no obstructive coronary artery. Cardiovasc Res. 2025;121(4):532\u20134.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"3068_CR78","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000335214","volume":"49","author":"A Ashoff","year":"2012","unstructured":"Ashoff A, Qadri F, Eggers R, Johren O, Raasch W, Dendorfer A. Pioglitazone prevents capillary rarefaction in streptozotocin-diabetic rats independently of glucose control and vascular endothelial growth factor expression. J Vasc Res. 2012;49(3):260\u20136.","journal-title":"J Vasc Res"},{"key":"3068_CR79","doi-asserted-by":"publisher","first-page":"117560","DOI":"10.1016\/j.atherosclerosis.2024.117560","volume":"394","author":"A Dardano","year":"2024","unstructured":"Dardano A, Bianchi C, Garofolo M, Del Prato S. The current landscape for diabetes treatment: preventing diabetes-associated CV risk. Atherosclerosis. 2024;394:117560.","journal-title":"Atherosclerosis"},{"issue":"7","key":"3068_CR80","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11892-018-1011-7","volume":"18","author":"DZ Khat","year":"2018","unstructured":"Khat DZ, Husain M. Molecular mechanisms underlying the cardiovascular benefits of SGLT2i and GLP-1RA. Curr Diab Rep. 2018;18(7):45.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"3068_CR81","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13098-023-01195-7","volume":"15","author":"S Hu","year":"2023","unstructured":"Hu S, Su X, Fan G. Efficacy and tolerability of the subcutaneous semaglutide for type 2 diabetes patients: an updated systematic review and meta-analysis. Diabetol Metab Syndr. 2023;15(1):218.","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"3068_CR82","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1210\/jc.2018-02685","volume":"104","author":"VA Fonseca","year":"2019","unstructured":"Fonseca VA, Capehorn MS, Garg SK, Jodar Gimeno E, Hansen OH, Holst AG, et al. Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide. J Clin Endocrinol Metab. 2019;104(9):4078\u201386.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"3068_CR83","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","volume":"37","author":"CN Bairey Merz","year":"2016","unstructured":"Bairey Merz CN, Handberg EM, Shufelt CL, Mehta PK, Minissian MB, Wei J, et al. A randomized, placebo-controlled trial of late Na current Inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. Eur Heart J. 2016;37(19):1504\u201313.","journal-title":"Eur Heart J"},{"issue":"10","key":"3068_CR84","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/biomedicines9101356","volume":"9","author":"T Di Salvatore","year":"2021","unstructured":"Salvatore T, Caturano A, Galiero R, Di Martino A, Albanese G, Vetrano E, et al. Cardiovascular benefits from gliflozins: effects on endothelial function. Biomedicines. 2021;9(10):1356.","journal-title":"Biomedicines"},{"issue":"1","key":"3068_CR85","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12933-022-01607-4","volume":"21","author":"L Leccisotti","year":"2022","unstructured":"Leccisotti L, Cinti F, Sorice GP, D\u2019Amario D, Lorusso M, Guzzardi MA, et al. Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART trial: a preliminary report. Cardiovasc Diabetol. 2022;21(1):173.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3068_CR86","doi-asserted-by":"publisher","first-page":"H1089","DOI":"10.1152\/ajpheart.00615.2024","volume":"328","author":"A Panwar","year":"2025","unstructured":"Panwar A, Malik SO, Adib M, Lopaschuk GD. Cardiac energy metabolism in diabetes: emerging therapeutic targets and clinical implications. Am J Physiol Heart Circ Physiol. 2025;328(5):H1089\u2013112.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"3068_CR87","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s42003-023-04663-y","volume":"6","author":"J Choi","year":"2023","unstructured":"Choi J, Matoba N, Setoyama D, Watanabe D, Ohnishi Y, Yasui R, et al. The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice. Commun Biol. 2023;6(1):278.","journal-title":"Commun Biol"},{"issue":"10","key":"3068_CR88","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00392-019-01443-9","volume":"108","author":"I Ikonomidis","year":"2019","unstructured":"Ikonomidis I, Pavlidis G, Katsimbri P, Andreadou I, Triantafyllidi H, Tsoumani M, et al. Differential effects of Inhibition of Interleukin 1 and 6 on myocardial, coronary and vascular function. Clin Res Cardiol. 2019;108(10):1093\u2013101.","journal-title":"Clin Res Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-03068-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03068-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03068-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:02:55Z","timestamp":1770987775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-025-03068-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3068"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-03068-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RS reports research grant from Abbott Vascular and speakers fee from Abbott. FR reports research grant from Abbott Vascular and Philips. The other authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}